Randomized placebo-controlled study comparing a leukotriene receptor antagonist and a nasal glucocorticoid in seasonal allergic rhinitis
about
Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and childrenAnti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and childrenAddition of anti-leukotriene agents to inhaled corticosteroids for chronic asthmaEmerging role of antileukotriene therapy in allergic rhinitisAntileukotrienes in upper airway inflammatory diseasesTreatment of congestion in upper respiratory diseases.Allergic inflammation in the unified airway: start with the noseEffects of monotherapy with intra-nasal corticosteroid or combined oral histamine and leukotriene receptor antagonists in seasonal allergic rhinitis.Therapeutic strategies for allergic diseases.Leukotrienes, leukotriene receptor antagonists, and rhinitis.Hay fever in adolescents and adults.Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma.Leukotriene receptor antagonist therapyLeukotriene receptor antagonists in the treatment of allergic rhinitis.Addition of anti-leukotriene agents to inhaled corticosteroids for chronic asthma.The cost of treating allergic rhinitis.BSACI guidelines for the management of allergic and non-allergic rhinitis.Consensus Group on New-Generation Antihistamines (CONGA): present status and recommendations.Actual therapeutic management of allergic and hyperreactive nasal disordersThe emerging role of leukotriene modifiers in allergic rhinitis.Montelukast in allergic rhinitis: a systematic review and meta-analysis.The role of antileukotriene drugs in management of rhinitis and rhinosinusitis.The effect of combined medical treatment on quality of life in persistent allergic rhinitisTherapeutic management of allergic diseases.Nasobronchial interaction.Combination therapy with anti-mediator drugs in allergic disease.A comparison of topical budesonide and oral montelukast in seasonal allergic rhinitis and asthma.Effect of seasonal allergen exposure on mucosal IL-16 and CD4+ cells in patients with allergic rhinitis.Montelukast for treating seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial performed in the spring.Montelukast as an adjuvant to mainstay therapies in patients with seasonal allergic rhinitis.Montelukast plus cetirizine in the prophylactic treatment of seasonal allergic rhinitis: influence on clinical symptoms and nasal allergic inflammation.Randomized placebo-controlled trial comparing fluticasone aqueous nasal spray in mono-therapy, fluticasone plus cetirizine, fluticasone plus montelukast and cetirizine plus montelukast for seasonal allergic rhinitis.Role of leukotriene inhibitors in the postoperative management of nasal polyps.Randomized placebo-controlled trial comparing montelukast and cetirizine for treating perennial allergic rhinitis in children aged 2-6 yr.Glucocorticoids and immunoglobulin E: no new in vivo paradigmsUpregulation of nasal mucosal eotaxin in patients with allergic rhinitis during grass pollen season: effect of a local glucocorticoidAllergic rhinitis
P2860
Q24197682-065C1681-2BE0-4185-8DA1-8E4CB67BF958Q24247433-CF41BFC1-8549-471E-AA24-B4B4836EBF34Q24247489-22909CCC-1944-4CFF-A44B-A53DCB5A9A6DQ28191844-48904E31-49C0-414C-A0D4-371D68849C58Q28267571-0DF5B99D-5193-422C-95ED-4C4CFB40D7D6Q30481520-0493BE4F-EF5E-4A1E-B31B-BDBD836351EBQ30496381-19A9FD8E-59F8-43E4-BA93-2EB1EA127BB3Q31894371-9C70AE8F-A5A7-4D15-9630-B3CF59E919EFQ33787614-CD213798-1624-4A5F-B16A-B0B5B0FD9384Q33937511-C5BEAA83-4827-4DEB-9A46-AE7AD3467D98Q33949990-868BF10A-37DB-47A7-BD8D-BA6DDB85249CQ33978718-83341501-04EE-47CA-9B73-3866E2BEEC74Q34086351-4E775D1E-1F93-4EC8-9246-4EBDA7F235CAQ34417326-F4843857-276E-4108-A578-8E65A3446F67Q34424227-D46211DF-CD03-431D-904A-5D10C08D1F99Q34579822-5A7473A1-B50C-40AD-B1D9-28E466DAE67DQ34725718-7CA54AE7-2E8F-4830-81FB-9D56BF534A36Q35212261-4FEAAFF9-B15D-46D0-8227-4CE94D66527AQ35427205-6DCC5D3E-CCC3-4481-8C77-93740FE4112DQ35627607-0C190CBF-4D6F-491F-9610-AB1DE987FC3CQ36609797-95816AC9-F813-4251-ADDD-AFA08AA6C95BQ36797412-1C741071-B003-419F-938C-429EE39683CEQ37083339-179EBDC2-9B7C-4355-A323-B65097B0CD6FQ37550543-7846A2E9-3F53-4B5F-A48A-594A9195C423Q38532047-4D927665-4949-4BA5-97E4-1D96DB968B48Q43522675-82A37A99-21B7-40EB-B6EC-528345CB142CQ43612606-4942F6E3-2A0C-49FF-A06F-6D8F37CB3383Q43733451-80FF7DE5-35AE-462D-9BE7-9ADCAA391233Q44051767-0210C9D1-B662-4201-8C23-2F02FABDFC0DQ44474645-C06750B7-077E-45F6-8784-5D627F1807B6Q44775744-202739B5-0842-4B49-828C-6FE76BB77721Q44778643-5ADF753A-2377-4EC2-8DDA-AE6D3511BAF3Q46519007-BC0C0CE7-2A57-4453-9C30-07B9292071D4Q46903579-4551C415-0F56-4D6F-B274-C34589F6073CQ57085047-DF581AA7-83B4-4ECF-8A3E-7F3764422176Q57085051-584DB82E-9562-4446-95A9-380543E89B15Q58745869-F5DDE619-35AF-42AB-91A0-8A4B483A153D
P2860
Randomized placebo-controlled study comparing a leukotriene receptor antagonist and a nasal glucocorticoid in seasonal allergic rhinitis
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Randomized placebo-controlled ...... in seasonal allergic rhinitis
@ast
Randomized placebo-controlled ...... in seasonal allergic rhinitis
@en
Randomized placebo-controlled ...... in seasonal allergic rhinitis
@nl
type
label
Randomized placebo-controlled ...... in seasonal allergic rhinitis
@ast
Randomized placebo-controlled ...... in seasonal allergic rhinitis
@en
Randomized placebo-controlled ...... in seasonal allergic rhinitis
@nl
prefLabel
Randomized placebo-controlled ...... in seasonal allergic rhinitis
@ast
Randomized placebo-controlled ...... in seasonal allergic rhinitis
@en
Randomized placebo-controlled ...... in seasonal allergic rhinitis
@nl
P2093
P2860
P1476
Randomized placebo-controlled ...... in seasonal allergic rhinitis
@en
P2093
P2860
P304
P356
10.1164/AJRCCM.159.6.9810016
P407
P50
P577
1999-06-01T00:00:00Z